Commit To Purchase Aclaris Therapeutics At $0.50, Earn 23.4% Annualized Using Options
March 13, 2024 at 14:10 PM EDT
Investors considering a purchase of Aclaris Therapeutics Inc (ACRS) stock, but tentative about paying the going market price of $1.29/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the August put at the $0.50 strike, which has a bid at the time of this writing of 5 cents..